Asthma UK Centre for Applied Research

Project: AAMOS-00

Mobile device monitoring to inform prediction of asthma attacks: an observational study

Smart monitoring, mHealth and machine learning

Smart monitoring devices and mobile-health (mHealth) technologies are used more and more to help with asthma self-management. These technologies, including smartwatches and smartphones, give new ways for people with asthma to monitor their condition with the least interruption to their lives. Smart devices can replace the burden of daily monitoring, helping people to look after their asthma so that they manage their treatment and avoid attacks. Examples are smart inhalers and smart watches.

When mHealth is combined with tailored feedback, this can replace the burdensome task of daily monitoring, leading to a better level of care for patients and thus less asthma attacks and a peace of mind.

Our study consists of:

  • Phase 1 - daily questionnaire monitoring for one month
  • Phase 2 - smart device monitoring for six months

Collecting data

To develop a useful and safe system for people with asthma, we need to collect information using new smart technologies alongside the traditional daily symptom and peak flow diary. We can then compare the two sets of readings to develop systems that detect worsening asthma using smart devices and potentially reducing the need for burdensome data entry.

The aim of this study is to collect these two sets of data from about 30 people for 6 months. We’ll use the findings to develop a method that can accurately predict an asthma attack smart devices and symptom diaries. In the future this could be used in a connected asthma system to help people look after their asthma and avoid troublesome attacks.

Want to get involved in Phases 1 and 2?

  • Are you 18 and above?
  • Have you been diagnosed with asthma by a doctor?
  • Do you have:
    • An Android smartphone from 2016 onwards (e.g. Samsung Galaxy S7, Xiaomi Mi 5, Huawei P9) with Bluetooth?
    • An iPhone 7 or later with Bluetooth?
  • Have you had at least one course of oral corticosteroids (Prednisone, Medrol, etc.), for an acute asthma attack, in the past 12 months? 

If you answered yes to the questions above, you may be eligible for this study.

Key People

Headshot of Kevin Tsang

Kevin Tsang

Headshot of Ahmar Shah

Syed Ahmar Shah

Asthma UK Centre for Applied Research PhD student Chancellor's Fellow
Based at: University of Edinburgh Based at: University of Edinburgh
Kevin's PhD Profile Ahmar's Profile
headshot of Hilary Pinnock

Hilary Pinnock

Headshot of Andrew Wilson

Andrew Wilson

Lead: Optimising management of asthma attacks

Lead: Postgraduate Training, Network Coordinator

Lead: Preventing asthma attacks
Based at: University of Edinburgh Based at: University of East Anglia
Hilary's Profile Andrew's Profile

Contact us

If you have any questions about this study, get in touch:

Kevin Tsang

Dr Ahmar Shah

Partners

We thank Mobistudy for their support with data collection.
mobistudy logo
We thank Smart Respiratory Products Ltd for providing the Smart Peak Flow Meter and associated software.
smart asthma logo
We thank FindAir for providing the FindAir ONE devices and FindAir's API.
Findair logo

We thank Ambee for providing the pollen data.

ambee logo

Funding

This work is funded by Asthma UK as part of the Asthma UK Centre for Applied Research [AUK-AC-2012-01 and AUK-AC-2018-01].

Privacy Statement

Find out how the AAMOS-00 study uses your information

AAMOS-00 Privacy Statement